WARREN, N.J., Dec. 7, 2018 /PRNewswire/ — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs, today announced that management will present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference to be held in New York, NY on December 12.
Aquestive will present on Wednesday, December 12 at 10:40 a.m. Eastern Time. A webcast of the presentation will be available on the “Investors” section of the Investor Relations page on our website. For more information, please visit investors.aquestive.com.
About Aquestive Therapeutics
Aquestive Therapeutics is a specialty pharmaceutical company committed to identifying, developing and commercializing differentiated products to address unmet medical needs. Aquestive Therapeutics has a late-stage proprietary product pipeline focused on the treatment of CNS diseases, and is working to advance orally-administered complex molecules that it believes can be alternatives to invasively-administered standard of care therapies. As the leader in developing and delivering drugs via its PharmFilm® technology, Aquestive Therapeutics also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.
View original content to download multimedia:http://www.prnewswire.com/news-releases/aquestive-therapeutics-to-present-at-the-bmo-capital-markets-2018-prescriptions-for-success-healthcare-conference-300761690.html
SOURCE Aquestive Therapeutics, Inc.